2020 annual financial data

Prelude Therapeutics Incorporated 2020 Operating margin

Prelude Therapeutics Incorporated 2020 operating margin with verified reported…

Direct answer

Operating margin was Not calculable.

Operating income was -58,763,000 USD and net income was -56,929,000 USD.
Operating cash flow was -46,177,000 USD.

Get free Prelude Therapeutics Incorporated email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-58,763,000 USD
Net income
-56,929,000 USD
Operating cash flow
-46,177,000 USD